The first mice with characteristics of celiac disease have been developed at the University of Chicago Celiac Disease Center. For the first time researchers can observe celiac disease onset as the mouse’s immune system launches a coordinated attack against gluten.
Continue ReadingThe Celiac Disease Foundation uses peer-reviewed research to push our federal government to act responsibly. Our sponsorship of Columbia University’s Biennial Symposium, where the world’s expert celiac researchers share their findings and collaborate on future projects, continues this work.
Continue ReadingThere may be a silver lining in the COVID-19 cloud. The pandemic might actually improve diagnostic rates and follow-up care for people with celiac disease. Celiac disease clinics have begun to…
Continue ReadingDr. Dan Leffler, Celiac Disease Foundation Medical Advisory Board Member and clinician and researcher at Harvard Medical School and Takeda, spoke about the profound ineffectiveness and failure of the gluten-free diet as a treatment for celiac disease.
Continue ReadingOur valued sponsors and vendors are committed to providing gluten-free products in this time of need.
Continue ReadingAmidst the uncertainty of the future, we have made the difficult decision to cancel the Celiac Disease Foundation’s Gluten-Free EXPO scheduled for June 13 – June 14, 2020, and not reschedule this year.
Continue ReadingThe Celiac Disease Foundation National Patient Advocacy Summit in Washington, DC will train participants to advocate on celiac disease public policy priorities to Members of Congress.
Continue ReadingThe Celiac Disease Foundation, the nation’s leading disease advocacy organization for celiac disease, announces the appointment of officers to its Board of Directors.
Continue ReadingIn partnership with Celiac Cruise, the Celiac Disease Foundation was proud to embark on the inaugural sailing aboard Royal Caribbean’s Mariner of the Seas, January 17-20, 2020, and strengthen community relationships in gluten-free paradise.
Continue ReadingOn December 11, 2019, CEO Marilyn G. Geller was with Senator Blumenthal's legislative staff as Senator Richard Blumenthal (D-CT) introduced S.3021: Gluten in Medicine Disclosure Act of 2019 to the Senate. The Celiac Disease Foundation is proud to be a partner in this effort.
Continue ReadingDear Celiac Disease Foundation Community, For more than three decades, the Celiac Disease Foundation has been dedicated to improving the lives of those affected by celiac disease through research, advocacy, and education. What began as a grassroots effort has grown into a global organization, leading the charge in accelerating diagnosis,...